Canopy Growth Corp (nasdaq:CGC) Share Price

Company Profile

Business description
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
Contact
1 Hershey Drive
Smiths FallsONK7A 0A8
CAN
T: +1 855 558-9333
https://www.canopygrowth.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
1,128

Recommended

Companies with US exposure are better positioned to benefit from easing prohibition, writes Kristoffer Inton.

Kristoffer Inton | 26 October 2020

Morningstar thinks these companies are well positioned to benefit from one of five key trends during the next decade, writes Susan Dziubinski.

Susan Dziubinski | 01 October 2020

In ten years’ time, you won’t be illegally smoking cannabis, you’ll be legally eating it. Here are some stocks to watch.

Lex Hall | 22 September 2020

Index	Last price	Change	% Change
All Ordinaries	8,896.50	9.90	-0.11%
CAC 40	8,116.76	0.00	0.00%
DAX 40	25,361.15	215.30	-0.84%
Dow JONES (US)	52,064.10	316.56	-0.60%
FTSE 100	10,608.92	61.14	-0.57%
HKSE	24,660.32	294.15	-1.18%
NASDAQ	26,081.72	171.62	-0.65%
Nikkei 225	63,327.51	1,943.44	-2.98%
NZX 50 Index	13,635.56	75.45	-0.55%
S&P 500	7,591.70	44.66	-0.58%
S&P/ASX 200	8,715.50	2.40	-0.03%
SSE Composite Index	3,874.63	59.77	-1.52%